| No headlines available for FBTCX. |
| | | Morningstar Overall Rating: |  | | Total Assets: | 11.14M | | Category: | Health | | Total Expense Ratio: | % |
|
| PERFORMANCE & RISK | 30-Nov-09 |
| YTD Return: | 4.31% | | 5y Avg Return: | 1.67% | | Rank in Category (ytd): | 156 | | % Rank in Category (ytd): | 94.55% | | Beta (3y): | 0.59 | | Morningstar Risk Rating: | Above average |
|
| The investment seeks capital appreciation. The fund invests 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. The fund is nondiversified. | | | Fund Profile |
|
Help
0.06 (0.94%) 
Summary
Add FBTCX to Portfolio 
Download Data
